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INTRODUCTION
Positron emission tomography (PET) is widely used to evalu-
ate metabolic changes in neurodegenerative disorders.1 PET 
with 18F-2-fluoro-2-deoxyglucose ([F-18]FDG) as a tracer can 
confirm neuronal function by demonstrating glucose con-
sumption. Reduced glucose metabolism in specific areas is a 
common feature of Alzheimer’s disease (AD), with reductions 
in both the hippocampal and cortical regions being demon-
strated by [F-18]FDG-PET imaging.2,3 Basal forebrain cholin-
ergic neuronal degeneration is also a common feature of AD. 
An association between cholinergic deficits and memory dys-
function has been reported in many clinical studies and ani-
mal experiments.4,5 For example, rats with experimentally le-
sioned cholinergic neurons show substantial spatial learning 
and memory impairments.6,7 
Although brain regions representing glucose hypometabo-
lism in AD are target sites of basal forebrain cholinergic neu-
rons, the interaction between cholinergic denervation and 
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glucose hypometabolism is still unclear. Some studies have 
suggested that even though there is a reduction in glucose 
metabolism due to cholinergic damage, recovery without 
cholinergic recovery occurs after 3 weeks to 3 months.8-10 
However, another study reported reduced glucose metabo-
lism for 4.5 months after cholinergic damage.11 
We have previously shown that selective basal forebrain 
cholinergic neuronal damage by the immunotoxin 192 im-
munoglobulin G-saporin causes spatial memory impairment, 
which is related to hippocampal cholinergic dysfunction, as 
well as damage to the frontal cortex.12 The present study aimed 
to evaluate glucose metabolism changes caused by basal fore-
brain cholinergic neuronal damage and confirm the region of 
dysfunction.
MATERIALS AND METHODS
Animals
All animal experiments were conducted according to the 
Guide for the Care and Use of Laboratory Animals of the Na-
tional Research Council (USA). Rats were housed in plastic 
cages with food and tap water available ad libitum. A 12-h 
dark/light cycle was maintained in a temperature and humid-
ity controlled room. All behavioral training and testing oc-
curred during the light phase. Twenty-four male Sprague-
Dawley rats weighing 200–250 g were randomly assigned to 
one of two experimental groups before surgery. The normal 
group (n=12) underwent no surgical procedure. The lesion 
group (n=12) received an intraventricular administration of 
192 IgG-saporin.
Surgical procedure
All rats in the lesion group were anesthetized with a mixture 
of ketamine (75 mg/kg), acepromazine (0.75 mg/kg), and 
rompun (4 mg/kg), and secured in a stereotaxic frame. After a 
scalp incision, two holes were drilled in the skull at the stereo-
taxic coordinates of 0.8 mm posterior and ±1.2 mm lateral 
from the bregma. Rats were injected bilaterally with 8 μL of 
192 IgG-saporin (0.63 μg/μL, Chemicon, Temecula, CA, USA) 
3.4 mm below the cortical surface. The solutions were deliv-
ered at 1 μL/min. The syringe was left in place for 5 min after 
injection.
Behavioral test-Morris water maze
Three weeks after surgery, seven rats from each group were 
trained in the Morris water maze as previously described.12 
Briefly, the testing consisted of training trials for 5 days (4 tri-
als/day) with a platform in a fixed position and a 1 day probe 
trial without a platform. Rats not reaching the platform within 
60 s were led to the platform by the experimenter and allowed 
to remain there for 10 s. Forty-eight hours after the last train-
ing trial, rats underwent the probe trial, lasting 60 s, during 
which the platform was removed from the pool. Swim paths 
were recorded using a video tracking system above the center 
of the pool.
MicroPET
Three weeks after surgery, five rats from each group were de-
prived of food for 12–15 h to enhance [F-18]FDG uptake in the 
brain. Each animal was warmed and adapted to a sound-at-
tenuated booth (maintained at 30°C) with 60 dB of white 
noise for at least 30 min before [F-18]FDG injection. [F-18]
FDG (500 mCi/100 g body weight) was injected through the 
tail vein without anesthesia. After [F-18]FDG uptake (40 min), 
imaging was performed using a Focus 120 MicroPET system 
(Concorde Microsystems, Knoxville, TN, USA). During the 
PET scans (40 min), animals were maintained under isoflu-
rane inhalation anesthesia (2% in 100% oxygen; IsoFlo; Abbott 
Laboratories, Quebec, Canada).
Histological evaluation
After behavioral testing, 10 rats from each group were per-
fused with cold 4% paraformaldehyde. Their brains were re-
moved, post-fixed, and placed in 30% sucrose for 3 days. The 
brains were sectioned at 30 μm using a freezing microtome 
and stored in cryoprotectant solution [-20°C; 0.1 M phosphate 
buffer (pH 7.2), 30% sucrose, 1% polyvinylpyrrolidone, and 
30% ethylene glycol]. Anatomical landmarks were used to lo-
calize the medial septum (MS) and cingulate cortex (CC).13 To 
detect choline acetyltransferase (ChAT)-immunopositive cells 
in the MS, brain sections were immunohistochemically pro-
cessed using polyclonal antibodies against ChAT (Chemicon, 
Temecula, CA, USA). To detect GABAergic cells in the CC, 
brain sections were processed using glutamate decarboxylase 
(GAD) 65/67 polyclonal antibodies (Millipore, Temecula, CA, 
USA).
Acetylcholinesterase (AChE) assay 
To acquire protein for the acetylcholinesterase (AChE) assay, 
two rats from each group were anesthetized with a mixture of 
ketamine, acepromazine, and rompun. The brains were 
quickly removed and the CC dissected to yield a sample in a 1 
mm coronal brain slice. The samples were homogenized in 
lysis buffer (Intron, Seongnam, Korea) and centrifuged for 15 
min at 13000 rpm. Protein in the supernatant was measured 
using a bicinchoninic acid protein assay reagent kit (Pierce, 
Rockford, IL, USA). Protein samples were stored at -20°C and 
the enzymatic activity of AChE determined using the method 
of Ellman, et al.14 with some modifications. Briefly, triplicate 
samples (20 μL) were added to the reaction mixture [0.2 mM 
dithiobisnitrobenzoic acid (Sigma, St. Louis, MO, USA), 0.56 
mM acetylthiocholine iodide (Sigma), 10 μM tetraisoprpyl-
pyrophosphoramide (Sigma), and 39 mM phosphate buffer, 
pH 7.2] at 37°C. After 30 min, the optical density (OD) was 
measured at 405 nm.
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Data analysis
Water maze probe test results were expressed as a percentage 
of the normal group. An independent t test was used to ana-
lyze for significant differences between the two groups. A p 
value <0.05 was considered statistically significant. All statisti-
cal analyses were performed using PASW software (version 
18; SPSS Inc., Chicago, IL, USA). For statistical analysis, brain 
regions in the [F-18]FDG microPET images were manually 
extracted. Individual images were normalized using the [F-18]
FDG rat brain template. To make the [F-18]FDG rat brain tem-
plates, normal rat brain images (n=12) were co-registered to 
the respective images and re-sliced with trilinear interpola-
tion (0.4×0.4×0.4 mm3) using SPM5 (http://www.fil.ion.ucl.
ac.uk/spm). Values from individual images were averaged to 
make the [F-18]FDG rat brain template. It was then normal-
ized to an MRI template for accurate anatomical information 
in stereotaxic space.15 Voxel-based statistical analyses were 
carried out between the normal and lesion groups using a t 
test.
The statistical threshold was set at p<0.05 (family-wise error 
correction) with an extent threshold of 100 contiguous voxels. 
T value maps of results were overlaid on transverse views of 
the MRI template to define voxels showing significant chang-
es. For correlation analyses among the brain areas with signif-
icant metabolic changes, the average glucose metabolism of 
all voxels in each activated or deactivated brain region was 
calculated at the Paxino’s position of each region.
RESULTS 
Cholinergic lesion of the MS
Intraventricular 192 IgG-saporin injections produced ChAT-
immunopositive neuronal denervation in the MS. ChAT-im-
munopositive neurons in normal rats were evenly distributed 
in the MS, with the cell body structure and dendrites com-
Fig. 1. Representative images showing effects of the cholinergic lesion. (A) The normal group has numerous ChAT-immunopositive neurons in the MS. (B) 
The lesion group displays a loss of cholinergic neurons in the MS. Scale bar represents 500 μm. ChAT, choline acetyltransferase; MS, medial septum.
A B
Fig. 2. Cholinergic deficit effects on spatial memory. (A) Latency indicates the time required for the rat to find the escape platform during training trials. All 
groups showed a similar latency of 10 s on the last day of the training trial, suggesting they remembered the platform location. Data are shown as 
mean±standard error of the mean. (B) During the probe test, the time spent in the target quadrant (*p<0.05) and in the platform zone (*p<0.05) is signifi-
cantly different between the lesion and normal groups. Indices are expressed as the percentage of normal group values.
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pletely intact (Fig. 1A). In contrast, the lesion group showed a 
remarkable decrease in the number of ChAT-immunopositive 
neurons and severe damage to the cell bodies and dendrites 
(Fig. 1B). 
Spatial memory impairment
On the first training trial day, the latencies of normal and le-
sion group rats to reach the platform were 34.9 and 38.1 s, re-
spectively, which was not significantly different (Fig. 2A). Both 
groups showed similar latencies (12 s) on the last training trial 
day, suggesting that latency to reach the platform declined 
progressively across training days and both groups progres-
sively learned the hidden platform location. During the probe 
test (Fig. 2B), the lesion group showed no difference from the 
normal group in motor-related behaviors, as evidenced by 
similar swim distances and speeds. These findings suggest 
cholinergic lesions do not affect motor function. However, the 
amount of time spent by the lesion group in the target quad-
rant and platform zone decreased to 60% (p<0.05) and 36% 
(p<0.05) of normal group values, respectively. These differ-
ences were statistically significant. Moreover, the number of 
platform crossings decreased to 38% of the normal group, 
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Fig. 3. Changes in glucose metabolism in coronal (A-F), horizontal (G), and sagittal (H) brain sections from rats. Significant declines (p<0.05) in glucose 
metabolism are seen in the bilateral cingulate and motor cortices of the lesion group.
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though this difference was not statistically significant.
Hypometabolism in the CC
Fig. 3 shows changes in glucose metabolism in coronal (Fig. 
3A-F), horizontal (Fig. 3G), and sagittal (Fig. 3H) sections in 
rats. Coronal sections indicating glucose hypometabolism 
were located 0.6 mm to -1.4 mm from bregma (Fig. 3A-F). A 
significant decrease (p<0.05) in glucose metabolism was 
found in the bilateral cingulate and motor cortices of the le-
sion group. There were no significant differences in glucose 
metabolism of other regions, including the hippocampus and 
basal forebrain.
Changes in neurotransmitter activity
In the normal group, AChE activity in the CC was measured as 
an OD of 0.56. In contrast, the lesion group had an OD value 
of 0.54. This difference was significant (p<0.05) (Fig. 4), sug-
gesting cholinergic neuron damage in the basal forebrain by 
192 IgG-saporin reduced CC cholinergic activity.
GAD65/67, which is responsible for basal GABA synthesis, 
revealed GABAergic cells in the CC. GAD65/67-immunoposi-
tive cells were densely distributed in the CC of normal rats 
(Fig. 5A). The lesion group showed a notable decline in the 
number of GAD65/67-immunopositive cells (Fig. 5B).
DISCUSSION
In this study we showed that animals with sufficient basal 
forebrain cholinergic neuronal damage to cause spatial mem-
ory impairment exhibit a reduction in CC glucose metabolism 
and a reduction of both the cholinergic and GABAergic sys-
tems. 
Basal forebrain cholinergic projections to the CC are veri-
fied by histologic studies. Electrolytic lesions of the MS and 
diagonal band region reduce diffuse AChE staining in the 
CC.16 A study using a fluorescent AChE tracer showed that 
pathways to the CC are derived from all subdivisions of the di-
agonal band and nucleus basalis of Meynert (NBM).17 Animal 
tests examining the relationship between basal forebrain cho-
linergic neuron deficits and cerebral glucose metabolism 
have been conducted. In a comparative study on uni- and bi-
lateral NBM damage, unilateral damage did not cause a per-
manent reduction in cortical metabolism, whereas bilateral 
damage caused a persistent suppression of cortical glucose 
metabolism.18 A study of cholinergic neuronal damage via bi-
lateral intraventricular injection of 192 IgG-saporin reported 
sustained hippocampal and cortical hypometabolism for 4.5 
Fig. 4. Cholinergic deficit effects on AChE activity in the CC. AChE activity 
of the lesion group was significantly decreased compared with the nor-
mal group (*p<0.05). AChE activity is expressed as the OD at 405 nm. Val-
ues are the mean±standard error of the mean. AChE, acetylcholinester-
ase; OD, optical density; CC, cingulate cortex.
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Fig. 5. Representative images showing decreased GAD65/67 positive cells. (A) GAD65/67-immunopositive cells in normal rats are densely distributed in 
the CC. (B) The lesion group shows a notable decline of GAD65/67-immunopositive cells. Scale bar represents 500 μm. CC, cingulate cortex; GAD, gluta-
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months.11 In this study, damaged cholinergic neurons showed 
a significant reduction in CC glucose metabolism that was 
maintained for 3 weeks. However, in a study of left NBM dam-
age in baboons, even though significant metabolic depression 
of the entire ipsilateral CC was observed 4 days after lesioning, 
glucose metabolism slowly recovered to almost normal limits 
within 6–13 weeks.8 Hippocampal glucose metabolism was 
profoundly suppressed on the third week, but returned to 
control values after 3 months.9 After either uni- or bilateral 
NBM lesions with ibotenic acid, glucose metabolism de-
creased on the third day and recovered between 3 weeks to 3 
months.10,19,20 From studies of reported hypometabolism re-
covery, it appears possible to spared cholinergic function in 
intact areas by damaging only the NBM or MS. Alternatively, 
intraventricular injection of 192 IgG-saporin only damages 
cholinergic cells expressing nerve growth factor receptor p75, 
likely damaging most cholinergic projections from the basal 
forebrain to the cortex or hippocampus. Thus, differences in 
hypometabolism recovery may originate from different meth-
ods of cholinergic lesion.
It is well documented that the hippocampus plays an es-
sential role in the formation of memory.21,22 However, extra-
hippocampal structures, especially neocortical regions, have 
been investigated for crucial roles in long-term memory.23,24 
Animal studies show that a reduction in anterior CC (ACC) is 
associated with remote memory. Expression of c-fos, which is 
related to neuronal activity, increases after remote memory 
water maze testing, but not with recent memory testing.25 In 
addition, pharmacological inactivation of the ACC impairs re-
trieval of 15- and 29-day memories,26 and electrophysiological 
activity of ACC neurons is increased while testing long-term 
memory.27 Furthermore, long-term fornix/hypothalamus 
deep-brain stimulation has been shown to enhance memory 
in patients with AD through memory circuit activation and al-
tered ACC glucose metabolism.28 Together with the above stud-
ies, spatial memory impairment concurrent with ACC dys-
function supports an important role for the ACC in long-term 
memory. 
Memory impairment following a basal forebrain choliner-
gic lesion appears related to glutamatergic, GABAergic, and 
cholinergic system dysfunction. The CC has receptors for ace-
tylcholine, GABA, and glutamate.29,30 The fact that neurotrans-
mitter systems in the CC are related to memory processing 
has been reported in a pharmacological study.31 Additionally, 
the initial increase and subsequent reduction of GABA during 
cognitive testing has been reported.32 Glucose metabolism, 
measured by PET, appears closely associated with glutamate-
driven activation of cells.33 Furthermore, animal research has 
examined the effects of basal forebrain cholinergic damage in 
the glutamatergic system. Some animal studies have reported 
decreases in cortical and hippocampal glutamatergic trans-
missions after NBM lesions,34 whereas others have reported 
different responses based on the type and location of gluta-
matergic receptors.35,36 
No significant differences in hippocampal glucose metabo-
lism we observed in this study. In our previous study, we eval-
uated 192 IgG-saporin effects on the expression of activity-
regulated cytoskeleton associated protein (Arc) and GAD. We 
found they were significantly decreased in the frontal cortex, 
but not in the hippocampus.12 The effects of basal forebrain 
cholinergic deficits caused by 192 IgG-saporin appear to be 
greater in the frontal cortex than the hippocampus. However, 
hippocampal and cortical hypometabolism is reported 18 
weeks after a selective cholinergic lesion.11 Additionally, it is 
well known that there is a close connection between basal 
forebrain cholinergic neurons, hippocampal function, and 
spatial memory.37 Therefore, we cannot exclude hippocampal 
dysfunction from involvement in memory impairment.
Glucose hypometabolism in the [F-18]FDG-PET results was 
observed in the CC and motor cortex. However, we could not 
confirm differences between groups regarding motor-related 
behaviors (swim distance and speed). In our previous study, 
we evaluated the effects of 192 IgG-saporin by dose on swim 
speed and distance. In the 10 μL-injection group, both the 
speed and distances in water maze testing were slightly de-
creased compared to the normal group, though the differenc-
es were not significant.12 Thus, there may be motor dysfunc-
tion which could not evaluate with water maze testing, because 
we observed motor cortex dysfunction, using [F-18]FDG-PET, 
following 8-μL injection of 192 IgG-saporin.
This study shows the effects of cholinergic dysfunction on 
cognitive function (including spatial memory) and CC func-
tion. The CC is known for its role in regulation of mood, such 
as depression.38 We attempted to deduce if deficits in cholin-
ergic levels induced abnormal mood regulation via reduced 
CC function in patients with AD. AD presents with various be-
havioral and psychological symptoms besides cognitive dys-
function.39 The cause for these other symptoms may be ac-
counted for by various mechanisms, such as amyloid plaques 
and intraneuronal neurofibrillary tangles.40 This study shows 
that mood changes in patients with AD may be the direct re-
sult of cholinergic dysfunction. It proposes that cholinergic 
restoration could treat mood changes in AD. Unfortunately, 
we did not perform experiments to confirm this hypothesis in 
this study. Further studies of cholinergic restoration are need-
ed to provide additional evidence for its therapeutic effects on 
mood change.
In conclusion, we examined spatial memory impairment in 
an animal model mimicking cholinergic denervation seen in 
patients with AD. Cholinergic denervation appears to be as-
sociated with a decline in the functions of GABAergic, cholin-
ergic, and glutamatergic systems, correlating with glucose hy-
pometabolism in the CC.
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